Jarrod M Ellingson1,2, J Megan Ross2, Evan Winiger2,3, Michael C Stallings2,3, Robin P Corley2, Naomi P Friedman2,3,4, John K Hewitt2,3, Susan F Tapert5,6, Sandra A Brown5,6, Tamara L Wall5,6, Christian J Hopfer1,2. 1. Department of Psychiatry, University of Colorado School of Medicine, Aurora, CO, USA. 2. Institute for Behavioral Genetics, University of Colorado, Boulder, CO, USA. 3. Department of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA. 4. Institute for Cognitive Science, University of Colorado, Boulder, CO, USA. 5. Department of Psychiatry, University of California San Diego, San Diego, CA, USA. 6. Veterans Affairs San Diego Healthcare System, San Diego, CA, USA.
Abstract
AIMS: To examine whether moderate adolescent cannabis use has neurocognitive effects that are unexplained by familial confounds, which prior family-controlled studies may not have identified. DESIGN: A quasi-experimental, sibling-comparison design was applied to a prospective, observational study of adolescents with moderate cannabis use. Participants were recruited from 2001 to 2006 (mean age = 17 years). A second wave of data was collected from 2008 to 2013 (mean age = 24 years). SETTING: Two US metropolitan communities. PARTICIPANTS: A total of 1192 adolescents from 596 families participated in this study. Participants were primarily male (64%) and racially and ethnically diverse (non-Hispanic white = 45%). A sibling in each family was a clinical proband identified due to delinquent behaviors. Whereas prior family-controlled studies have used samples of primarily infrequent cannabis users (mean = 1-2 days/month), participants here endorsed levels of cannabis use comparable to findings from epidemiological cohort studies (mean = 7-9 days/month). MEASUREMENTS: Semi-structured clinical interviews assessed drug use, and a neuropsychological battery assessed cognitive abilities. Covariates included age at assessment, gender and alcohol use. FINDINGS: After correcting for multiple testing, a greater frequency and earlier onset of regular cannabis use were associated with poorer cognitive performance, specifically on tests of verbal memory. Further, after accounting for familial factors shared by siblings and alcohol use, poorer verbal memory performance was still associated with greater life-time frequency of cannabis use at wave 1 [b = -0.007 (-0.002, -0.012), adjusted P = 0.036]; earlier cannabis use at wave 2 [b = -0.12 (-0.05, -0.19), adjusted P = 0.006; b = -0.14 (-0.06, -0.23), adjusted P = 0.006]; and greater frequency of past 6 months use at wave 2 [b = -0.02 (-0.01, -0.03), adjusted P = 0.002; b = -0.02 (-0.01, -0.03), adjusted P = 0.008]. CONCLUSIONS: Moderate adolescent cannabis use may have adverse effects on cognitive functioning, specifically verbal memory, that cannot be explained by familial factors.
AIMS: To examine whether moderate adolescent cannabis use has neurocognitive effects that are unexplained by familial confounds, which prior family-controlled studies may not have identified. DESIGN: A quasi-experimental, sibling-comparison design was applied to a prospective, observational study of adolescents with moderate cannabis use. Participants were recruited from 2001 to 2006 (mean age = 17 years). A second wave of data was collected from 2008 to 2013 (mean age = 24 years). SETTING: Two US metropolitan communities. PARTICIPANTS: A total of 1192 adolescents from 596 families participated in this study. Participants were primarily male (64%) and racially and ethnically diverse (non-Hispanic white = 45%). A sibling in each family was a clinical proband identified due to delinquent behaviors. Whereas prior family-controlled studies have used samples of primarily infrequent cannabis users (mean = 1-2 days/month), participants here endorsed levels of cannabis use comparable to findings from epidemiological cohort studies (mean = 7-9 days/month). MEASUREMENTS: Semi-structured clinical interviews assessed drug use, and a neuropsychological battery assessed cognitive abilities. Covariates included age at assessment, gender and alcohol use. FINDINGS: After correcting for multiple testing, a greater frequency and earlier onset of regular cannabis use were associated with poorer cognitive performance, specifically on tests of verbal memory. Further, after accounting for familial factors shared by siblings and alcohol use, poorer verbal memory performance was still associated with greater life-time frequency of cannabis use at wave 1 [b = -0.007 (-0.002, -0.012), adjusted P = 0.036]; earlier cannabis use at wave 2 [b = -0.12 (-0.05, -0.19), adjusted P = 0.006; b = -0.14 (-0.06, -0.23), adjusted P = 0.006]; and greater frequency of past 6 months use at wave 2 [b = -0.02 (-0.01, -0.03), adjusted P = 0.002; b = -0.02 (-0.01, -0.03), adjusted P = 0.008]. CONCLUSIONS: Moderate adolescent cannabis use may have adverse effects on cognitive functioning, specifically verbal memory, that cannot be explained by familial factors.
Authors: Stacy Salomonsen-Sautel; Joseph T Sakai; Christian Thurstone; Robin Corley; Christian Hopfer Journal: J Am Acad Child Adolesc Psychiatry Date: 2012-05-26 Impact factor: 8.829
Authors: Maria Alice Fontes; Karen I Bolla; Paulo Jannuzzi Cunha; Priscila Previato Almeida; Flávia Jungerman; Ronaldo Ramos Laranjeira; Rodrigo A Bressan; Acioly L T Lacerda Journal: Br J Psychiatry Date: 2011-06 Impact factor: 9.319
Authors: Nicholas J Jackson; Joshua D Isen; Rubin Khoddam; Daniel Irons; Catherine Tuvblad; William G Iacono; Matt McGue; Adrian Raine; Laura A Baker Journal: Proc Natl Acad Sci U S A Date: 2016-01-19 Impact factor: 11.205
Authors: Nadia Solowij; Katy A Jones; Megan E Rozman; Sasha M Davis; Joseph Ciarrochi; Patrick C L Heaven; Dan I Lubman; Murat Yücel Journal: Psychopharmacology (Berl) Date: 2011-02-17 Impact factor: 4.530
Authors: Cindy L Ehlers; Ian R Gizer; Cassandra Vieten; David A Gilder; Gina M Stouffer; Philip Lau; Kirk C Wilhelmsen Journal: Addict Behav Date: 2009-09-19 Impact factor: 3.913
Authors: J Cobb Scott; Samantha T Slomiak; Jason D Jones; Adon F G Rosen; Tyler M Moore; Ruben C Gur Journal: JAMA Psychiatry Date: 2018-06-01 Impact factor: 21.596
Authors: Jarrod M Ellingson; Jesse D Hinckley; J Megan Ross; Joseph P Schacht; L Cinnamon Bidwell; Angela D Bryan; Christian J Hopfer; Paula Riggs; Kent E Hutchison Journal: Curr Behav Neurosci Rep Date: 2021-11-15
Authors: J Megan Ross; Jarrod M Ellingson; Maia J Frieser; Robin C Corley; Christian J Hopfer; Michael C Stallings; Sally J Wadsworth; Chandra A Reynolds; John K Hewitt Journal: Drug Alcohol Depend Date: 2021-11-27 Impact factor: 4.492
Authors: Emmet Power; Sophie Sabherwal; Colm Healy; Aisling O' Neill; David Cotter; Mary Cannon Journal: Psychol Med Date: 2021-01-27 Impact factor: 7.723
Authors: John F Curry; Yifrah Kaminer; David B Goldston; Grace Chan; Karen C Wells; Rebecca H Burke; Adrienne Banny Inscoe; Allison E Meyer; Shayna M Cheek Journal: J Am Acad Child Adolesc Psychiatry Date: 2021-08-06 Impact factor: 8.829